You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Automated Manufacture of Damage Detecting, Self-Healing Composite Cryogenic Pressure Vessels

    SBC: AURORA FLIGHT SCIENCES CORPORATION            Topic: T1002

    During Phase I, Aurora Flight Sciences and the University of Massachusetts Lowell propose to demonstrate the feasibility of enhancing a commercially available out-of-autoclave (OOA) carbon prepreg material system (e.g. IM7/5320) via embedded structural health monitoring (SHM) and self-healing capabilities, which can be manufactured by an automated fiber placement (AFP) machine. This proposed "sma ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  2. Novel Metal Organic Framework Synthesis for Spacecraft Oxygen Capture

    SBC: Busek Co., Inc.            Topic: T602

    Busek and University of Utah propose to develop novel metal organic framework (MOF) material to efficiently capture oxygen in spacecraft cabin environment. The proposed novel MOF is postulated to be capable of separating oxygen from ambient air with high efficiency, and at the same time, be stable to moisture and resistant to decomposition. In Phase I, our team shall synthesize the proposed MOF an ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  3. In-Situ EBCs for High Performance Composite Propulsion Components

    SBC: Physical Sciences Inc.            Topic: T1202

    Silicon Carbide based ceramic matrix composites (CMCs) offer the potential to fundamentally change the design and manufacture of aeronautical and space propulsion systems to significantly increase performance and fuel efficiency over current metal-based designs. Physical Sciences Inc. (PSI) and our team members at the University of California Santa Barbara (UCSB) will develop, design and fabricat ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  4. New heterocyclic inhibitors of filoviruses

    SBC: MICROBIOTIX, INC.            Topic: H

    DESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. New small molecule inhibitors of arenaviruses

    SBC: MICROBIOTIX, INC.            Topic: R

    DESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD, LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government